Back to search
FDAFDA · Food and drugs·Recall number D-0295-2019

Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma 1075 West Park One Drive Suite 100 Sugar Land, TX 77478. Product Code 70092-9035-05

Published December 19, 2018 · Recall initiated: November 21, 2018

Summary

FDA records drug Class III recall D-0295-2019, published December 19, 2018 and initiated November 21, 2018. Recalling firm: QuVa Pharma, Inc.; Status: Terminated; Reported quantity: 168 bags; Lot: Lot #:10016014 Exp. 01/06/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
QuVa Pharma, Inc.
Distributor
CA only
Lot
Lot #:10016014 Exp. 01/06/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx only, Compounded by: QuVA Pharma 1075 West Park One Drive Suite 100 Sugar Land, TX 77478. Product Code 70092-9035-05 recalled?

Yes. FDA published recall D-0295-2019 on December 19, 2018. Reported hazard: Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride

What should I do if I have this product?

Voluntary: Firm initiated · Telephone